Just looked back. VX 770 started phase 3 in May 2009. If history is any lesson, that means a bit more than 2.5 years between the beginning of phase 3 and FDA approval.
Just looked back. VX 770 started phase 3 in May 2009. If history is any lesson, that means a bit more than 2.5 years between the beginning of phase 3 and FDA approval.
Can anyone speculate on the timing between now and potential FDA approval? I'm assuming final results will be released in July or August. When does Phase III begin? Then how long until FDA approval?
Can anyone speculate on the timing between now and potential FDA approval? I'm assuming final results will be released in July or August. When does Phase III begin? Then how long until FDA approval?
At the risk of getting too far ahead of myself, does anyone know how these drugs would affect other drug regimens, e.g., enzymes, physical therapy, nebs? Will people continue these treatments? What is the experience of people on Kalydeco? Have they been continuing treatments? Thanks!
At the risk of getting too far ahead of myself, does anyone know how these drugs would affect other drug regimens, e.g., enzymes, physical therapy, nebs? Will people continue these treatments? What is the experience of people on Kalydeco? Have they been continuing treatments? Thanks!
How long do clinical trials last? How long from beginning of Phase 1 to FDA approval? How long between phases? If the Phase 2 trials for 661/770 have just begun, if the trials prove successful, when would the drug hit the market? Also, I wonder if it will be cheaper since vastly more people...
How long do clinical trials last? How long from beginning of Phase 1 to FDA approval? How long between phases? If the Phase 2 trials for 661/770 have just begun, if the trials prove successful, when would the drug hit the market? Also, I wonder if it will be cheaper since vastly more people...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.